EP1144628A3 - Gene de recepteur de vanilloide humain - Google Patents

Gene de recepteur de vanilloide humain

Info

Publication number
EP1144628A3
EP1144628A3 EP00982103A EP00982103A EP1144628A3 EP 1144628 A3 EP1144628 A3 EP 1144628A3 EP 00982103 A EP00982103 A EP 00982103A EP 00982103 A EP00982103 A EP 00982103A EP 1144628 A3 EP1144628 A3 EP 1144628A3
Authority
EP
European Patent Office
Prior art keywords
receptor gene
vanilloid receptor
human vanilloid
human
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00982103A
Other languages
German (de)
English (en)
Other versions
EP1144628A2 (fr
Inventor
Jeffrey N. Masters
Melissa H. Vos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of EP1144628A2 publication Critical patent/EP1144628A2/fr
Publication of EP1144628A3 publication Critical patent/EP1144628A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP00982103A 1999-11-12 2000-11-10 Gene de recepteur de vanilloide humain Withdrawn EP1144628A3 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43899799A 1999-11-12 1999-11-12
US438997 1999-11-12
PCT/US2000/031077 WO2001034805A2 (fr) 1999-11-12 2000-11-10 Gene de recepteur de vanilloide humain

Publications (2)

Publication Number Publication Date
EP1144628A2 EP1144628A2 (fr) 2001-10-17
EP1144628A3 true EP1144628A3 (fr) 2002-02-27

Family

ID=23742867

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00982103A Withdrawn EP1144628A3 (fr) 1999-11-12 2000-11-10 Gene de recepteur de vanilloide humain

Country Status (4)

Country Link
EP (1) EP1144628A3 (fr)
JP (1) JP2003513669A (fr)
CA (2) CA2359955A1 (fr)
WO (1) WO2001034805A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69819345T2 (de) 1997-08-20 2004-07-15 The Regents Of The University Of California, Oakland Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung
GB9826359D0 (en) * 1998-12-01 1999-01-27 Glaxo Group Ltd Novel receptors
US20020072101A1 (en) * 2000-01-21 2002-06-13 Gaughan Glen T. Novel human nucleic acid molecules and polypeptides encoding cation channels
US6455278B1 (en) 2000-02-08 2002-09-24 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding human vanilloid receptor VR3
AU2001234150A1 (en) * 2000-02-25 2001-09-03 Daiichi Pharmaceutical Co., Ltd. Novel protein and gene encoding the same
DE10013296A1 (de) * 2000-03-17 2001-09-20 Boehringer Ingelheim Pharma Neuer nichtselektiver Kationenkanal
JP3501775B2 (ja) * 2000-05-31 2004-03-02 ファイザー株式会社 ヒトバニロイド受容体様タンパク質
GB0026114D0 (en) * 2000-10-25 2000-12-13 Smithkline Beecham Plc New use
DE10257421A1 (de) * 2002-12-09 2004-07-08 Grünenthal GmbH Regulatorische Elemente im 5'-Bereich des VR1-Gens
WO2006005472A1 (fr) * 2004-07-15 2006-01-19 Bayer Healthcare Ag Diagnostics et therapies de maladies associees au recepteur vanilloide (vr1)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002503451A (ja) * 1998-01-22 2002-02-05 ザ・レジェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア カプサイシン受容体をコードする核酸配列
EP0943683A1 (fr) * 1998-03-10 1999-09-22 Smithkline Beecham Plc Homologue humain du récepteur vanilloide Vanilrep1

Also Published As

Publication number Publication date
CA2359955A1 (fr) 2001-05-17
EP1144628A2 (fr) 2001-10-17
WO2001034805A3 (fr) 2001-11-22
CA2428827A1 (fr) 2001-05-17
WO2001034805A2 (fr) 2001-05-17
JP2003513669A (ja) 2003-04-15

Similar Documents

Publication Publication Date Title
AU4943200A (en) Modified cytokine
AU5898800A (en) Atherosclerosis-associated genes
AU2101101A (en) Flexible armrest construction
AUPQ441699A0 (en) Pour-on formulations
AU6418498A (en) Human genes
AU5095000A (en) Receptor interacting protein rip3
AU2002252460A1 (en) Human cytokine receptor
AU1020201A (en) Human sphingosine kinase gene
EP1144628A3 (fr) Gene de recepteur de vanilloide humain
AUPQ262599A0 (en) Gene expression
AU1073501A (en) Histamine receptor
AU2001277980A1 (en) Human cytokine receptor
AU2376200A (en) Insulin-synthesis genes
AU6035398A (en) Human c5a-like receptor
AU7318700A (en) Novel transaldolase gene
AU5016200A (en) Diabetes gene
AU7654800A (en) Quinazolinones
AU7064500A (en) Human narcolepsy gene
AU1531901A (en) Human tnf receptor
AU7999300A (en) Novel human phosphodiesterase zcytor13
AU4456800A (en) Human hac3
AU4609101A (en) Cervical fitting
AU1773501A (en) Human single nucleotide polymorphisms
AU4711800A (en) Cytokine receptor mouse zcytor10
AU6871900A (en) Tsg-like gene

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010711

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

XX Miscellaneous

Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20030509

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030920